Eric Ketcham's guest appearances

Eric Ketcham

ACEP Frontline - Emergency Medicine

Ben Smith

Jim Williams

Sam Quinones

Jacob Avila

Sara Gray

Ashley Shreves

John Rogers

Darren Braude

Reuben Strayer

David Carr

Howie Mell

Daniel Moore

John Greenwood

Brian Levine

Esther Choo

OwlTail

Kathryn Hawk

On today’s ACEP Frontline, Dr. Ryan Stanton discusses the MAT 3-Rule for prescribing buprenorphine for the opioid use disorder patient. Recorded live at LAC18, ACEP experts Dr. Eric Ketcham and Dr. Kathryn Hawk talk about how helping the patient with opioid withdrawal symptoms, they are more likely to continue on a path to help and recovery. Listen in to this critical discussion to learn what you need to know about care for this growing population.Resource: COWS Score https://www.mdcalc.com/cows-score-opiate-withdrawal Survey Results: http://media.mycrowdwisdom.com.s3.amazonaws.com/acep/ACEP%20Frontline/%28STR-TA%29%20EMPRN%20-%20Buprenorphine%2C%203-day%20rule-Waiver%20training%2C%20and%20OUD%20survey%20.pdfFunding for this initiative was made possible (in part) by grant no. 1H79TI080816-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

On today’s ACEP Frontline, Dr. Ryan Stanton discusses the MAT 3-Rule for prescribing buprenorphine for the opioid use disorder patient. Recorded live at LAC18, ACEP experts Dr. Eric Ketcham and Dr. Kathryn Hawk talk about how helping the patient with opioid withdrawal symptoms, they are more likely to continue on a path to help and recovery. Listen in to this critical discussion to learn what you need to know about care for this growing population. Resource: COWS Score <a href="https://www.mdcalc.com/cows-score-opiate-withdrawal" rel="nofollow" target="_blank">https://www.mdcalc.com/cows-score-opiate-withdrawal</a> Survey Results: <a href="http://media.mycrowdwisdom.com.s3.amazonaws.com/acep/ACEP%20Frontline/%28STR-TA%29%20EMPRN%20-%20Buprenorphine%2C%203-day%20rule-Waiver%20training%2C%20and%20OUD%20survey%20.pdf" rel="nofollow" target="_blank">http://media.mycrowdwisdom.com.s3.amazonaws.com/acep/ACEP%20Frontline/%28STR-TA%29%20EMPRN%20-%20Buprenorphine%2C%203-day%20rule-Waiver%20training%2C%20and%20OUD%20survey%20.pdf</a> Funding for this initiative was made possible (in part) by grant no. 1H79TI080816-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Eric Ketcham, MD and Kathryn Hawk, MD – MAT 3-Rule

On today’s ACEP Frontline, Dr. Ryan Stanton discusses Medication Assisted Treatment for patients with opioid use disorder. Recorded live at LAC18, ACEP experts Dr. Eric Ketcham and Dr. Kathryn Hawk share the results of a survey from the Emergency Medicine Practice Research Network (EMPRN) about current practices for patients with an addiction disorder. Survey Results: http://media.mycrowdwisdom.com.s3.amazonaws.com/acep/ACEP%20Frontline/%28Indivior%29%20EMPRN%20-%20Buprenorphine%2C%203-day%20rule-Waiver%20training%2C%20and%20OUD%20survey.pdfFunding for this podcast was made possible (in part) by an unrestricted educational grant from Indivior Inc.For more information about EMPRN visit: https://www.acep.org/get-involved/emprn---make-your-voice-count/

On today’s ACEP Frontline, Dr. Ryan Stanton discusses Medication Assisted Treatment for patients with opioid use disorder. Recorded live at LAC18, ACEP experts Dr. Eric Ketcham and Dr. Kathryn Hawk share the results of a survey from the Emergency Medicine Practice Research Network (EMPRN) about current practices for patients with an addiction disorder. Survey Results: <a href="http://media.mycrowdwisdom.com.s3.amazonaws.com/acep/ACEP%20Frontline/%28Indivior%29%20EMPRN%20-%20Buprenorphine%2C%203-day%20rule-Waiver%20training%2C%20and%20OUD%20survey.pdf" rel="nofollow" target="_blank">http://media.mycrowdwisdom.com.s3.amazonaws.com/acep/ACEP%20Frontline/%28Indivior%29%20EMPRN%20-%20Buprenorphine%2C%203-day%20rule-Waiver%20training%2C%20and%20OUD%20survey.pdf</a> Funding for this podcast was made possible (in part) by an unrestricted educational grant from Indivior Inc. For more information about EMPRN visit: <a href="https://www.acep.org/get-involved/emprn---make-your-voice-count/" rel="nofollow" target="_blank">https://www.acep.org/get-involved/emprn---make-your-voice-count/</a>

Eric Ketcham, MD and Kathryn Hawk, MD - Medication Assisted Treatment EMPRN Survey Results